Skip to content

Active ingredient

Desvenlafaxine

68 finished FDA listings contain Desvenlafaxine as their only active ingredient.

FDA NDC Directory

Ingredient names as written by FDA
DESVENLAFAXINE, DESVENLAFAXINE FUMARATE MONOHYDRATE, DESVENLAFAXINE SUCCINATE
Dosage forms
Tablet, Extended Release, Tablet, Film Coated, Extended Release
Routes
Oral
Manufacturers / labelers
23
Strengths listed
100 mg/1 · 25 mg/1 · 50 mg/1
Brand names in FDA listings
Desvenlafaxine, Pristiq Extended-Release

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 734064

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 021992PF PRISM CV2008-02-293
NDA 204150ALEMBIC PHARMS LTD2013-03-044
ANDA 204172LUPIN2015-06-2910
ANDA 204003ALEMBIC2015-06-2916
ANDA 204028RUBICON RESEARCH2015-06-2914
ANDA 204083HIKMA2016-02-163
ANDA 204065ACTAVIS LABS FL2016-07-293
ANDA 210014YICHANG HUMANWELL2018-10-017
ANDA 204805PLATINUM2019-05-072
ANDA 211427MACLEODS PHARMS2025-01-152

Official labeling on DailyMed

Showing the 12 most recent of 44 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.